|
Michel Boussinesq,
M.D., Ph.D.
Directeur de Recherche
Institut de Recherche pour le
Développement (IRD)
911, Av. Agropolis BP 64501
34394 Montpellier Cedex 5, France
Telephone: (33) 04 67 41 61 62
E-mail: boussinesq@ird.fr
Dr. Michel Boussinesq,
Directeur de Recherche, Institut de Recherche pour le Developpement,
Montpellier, France
Michel Boussinesq, MD, PhD, has worked for more than 20 years on the
epidemiology of onchocerciasis and on the strategies to control the disease by
ivermectin chemotherapy. Most of his research has been conducted in Cameroon,
where he was seconded at the Centre Pasteur. The main objectives of his
activities were aimed at evaluating the effects of various regimens of
ivermectin on Onchocerca volvulus,
and at addressing the issue of the adverse events related to coinfection with
the filarial parasite Loa loa.
He has also participated, in collaboration with various partners, in research on
the modelling of population dynamics of onchocerciasis and loiasis, and on the
immunology of onchocerciasis and other nematodiasis. Presently, his researches
focus on the possible emergence of an ivermectin resistance in O. volvulus,
and on the relationship between onchocerciasis and epilepsy. Since 2000, Dr.
Boussinesq is a member of the Technical Consultative Committee of the African
Programme for Onchocerciasis Control (APOC) and he coordinates two teams
involved in the long-term impact assessment of APOC operations. He has been a
member of the Mectizan Expert Committee (2004-2007). At the french Institut de
Recherche pour le Developpement (IRD), he leads the team "Infectious Diseases"
of the Research Unit "Epidemiology and Prevention". Dr. Boussinesq has published
more than 100 scientific articles on onchocerciasis, loiasis, and other
helminthic diseases. |
|